Coping with stress

Your Name PSYC 101 Date Article Information Haller, J. (2023). Anxiety modulation by cannabinoids—The role of stress responses and coping. International Journal of Molecular Sciences, 24(21), 1-25. HYPERLINK "https://doi.org/10.3390/ijms242115777"https://doi.org/10.3390/ijms242115777 Summary Humans have complex systems that determine their capacities to withstand varying external and internal sources of stress. In this article, Haller focuses on the association of endocannabinoids with diverse pathological outcomes in individuals. For instance, Haller (2023) indicates that it affects anxiety development or resolution in dynamic ways. This aspect has drawn scientists’ interest to the potential of the endocannabinoid system in the development of anxiolysis drugs. As a result, Haller seeks to explore three critical interventions related to the system to uncover the approach’s feasibility in addressing stress-related issues in patients. These methods comprise the binding effect of pharmacologic agents, genetic alterations, and function-enhancers (Haller, 2023). Focusing on these areas seeks to understand the practical mechanisms researchers can recommend for inducing stress-reducing effects while targeting different aspects of the endocannabinoid. Such research is progressive and appropriate for advancing treatments. Haller recognized that the endocannabinoid system presents a unique approach to solving complex psychological-related patient issues. In this context, Haller’s (2023) investigation highlights compounds that experts can use to manipulate the system and induce anxiolytic reactions. He succeeds by confirming that endocannabinoid signaling enrichment triggers an anxiety-reducing effect. Other impactful messages comprise the revelation that cannabinoid ligands can affect varied neurotransmitters in different ways, allowing care providers to choose a desirable effect that suits their patients’ needs. For example, they can take advantage of the anxiety control of these compounds to relax their clients and improve their quality of life. They can also leverage other techniques, such as genetic manipulations or transporter inhibitors, to induce specific effects on the system. Irrespective of the approach employed, Haller’s (2023) article reveals the potenti...